Drug intelligence / Profile preview

nomegestrol

Development stage
Phase 3
Lead developer
Merck
Modality
Small Molecules
Administration
Oral
01

Overview

Nomegestrol is a synthetic progestogen and a derivative of 19-norprogesterone. It acts as a highly selective agonist of the progesterone receptor, with minimal affinity for other steroid receptors, thereby lacking significant androgenic, estrogenic, or glucocorticoid effects. It is primarily used in hormonal contraception (often in combination with estradiol) and in hormone replacement therapy for the treatment of menopausal symptoms and gynecological disorders such as dysmenorrhea or endometriosis. Beyond its reproductive health applications, nomegestrol has been investigated for its potential neuroprotective and immunomodulatory effects in multiple sclerosis, specifically to prevent postpartum relapses, although clinical trials in this indication have not demonstrated efficacy.

Brand names
Lutenyl
Other names
nomegestrol acetateNOMAc
02

Targets

mPRα (Membrane progesterone receptor alpha)AR (Adrenergic receptors)PR (Progesterone receptor)

Beyond the preview

Go deeper on nomegestrol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nomegestrol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call